²é¿´: 1636  |  »Ø¸´: 6
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

mollyzhang

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

[ÇóÖú] ÇóÖú¹ØÓÚרÀû²éѯµÄÒ»¸öÎÊÌâ!

×î½ü×÷¹ØÓÚÒ»¸ö°ÐµãµÄÎÄÏ×µ÷ÑÐ,
²éÁ˼¸¼Ò¹«Ë¾£¬
ÈçPamlico Pharmaceutical Inc£¬Axxam£¬Advinus Therapeutics,ÔÚÆä¹«Ë¾Ö÷Ò³ÉÏÓйØÓÚGPR120µÄÐÅÏ¢,µ«ÊÇÎÞÂÛ²éscifinder,»¹ÊÇderwent£¬»¹ÊÇÔÚÅ·ÖÞרÀû¾ÖºÍÃÀ¹úרÀû¾Ö¶¼Ã»ÓÐÕÒµ½¸Ã¹«Ë¾¸Ã°ÐµãµÄרÀû¡£ÏëÇë½Ìר¼ÒÊÇûÓÐÉêÇëרÀû£¿»¹ÊÇûÓй«¿ª£¿¡¡
ÔÚÌÀÄ·Ñ·Öв鵽µÄÐÅÏ¢
Pamlico Pharmaceutical is investigating    a G-protein coupled receptor 120  (GPR120) agonist for the potential treatment of  diabetes. In September 2011, the program was in lead optimization  [1226961]; in March 2013, this was still the case  [1390000]. In September 2011,  the company was seeking to outlicense its programs [1226961].
ÔÚ£²£°£±£±Äê¸Ã¹«Ë¾¾ÍÔÚoutlicense its programs£¬ÄÇÓ¦¸ÃÓÐרÀûÁ˰ɣ¿¡¡ÎªÊ²Ã´²é²»µ½ÄØ£¿

¸Ã¹«Ë¾ÍøÕ¾
http://www.pamlicopharma.com/Home/research


»¹ÓÐAxxam¡¡
http://www.axxam.com/discoverypro/discpro.asp

Advinus Therapeutics
http://www.advinus.com/pipeline.asp
ÔÚÌÀÄ·Ñ·Öв鵽µÄÐÅÏ¢
Advinus Therapeutics is investigating dual agonists of GPR40 and GPR120, for the potential treatment of type 2 diabetes [1231883], [1488118]. In October 2011, the program was in discovery and target identification was underway [1231883]; in October 2013, the program was listed as being under hit-to-lead development [1488118].   In October 2011, the company was seeking to outlicense the programs [1231883].

ÒÔÉϼ¸¼Ò¹«Ë¾¶¼²é²»µ½Æä¸Ã°ÐµãµÄרÀû£¬Çóר¼Ò½â»ó£¡²»Ê¤¸Ð¼¤£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

whatt

ľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
mollyzhang: ½ð±Ò+40 2013-11-12 09:42:02
yuanahen: ½ð±Ò-29, Â¥Ö÷·´À¡²Ù×÷ʧÎóʵ¼ÊÊÇ+5·Ö 2013-11-12 13:49:20
yuanahen: ½ð±Ò-6, Â¥Ö÷·´À¡´íÎó 2013-11-12 13:49:51
ÒýÓûØÌû:
4Â¥: Originally posted by mollyzhang at 2013-11-11 15:37:04
ÎÒÊÇÒòΪÔÚÌÀÄ·Ñ·Öв鵽ÒÔÉϵĹ«Ë¾ÔÚ×ö¸Ã°Ðµã, ËùÒÔÊÇÒÔ¹«Ë¾Ãû³Æ¼ìË÷µÄ,Æä´ÎÎÒÒÔ GPR120 (FFA4)Ò²¶¼Ã»ËÑË÷µ½ÉÏÊö¹«Ë¾µÄרÀû...

ÎÒÒ²¾­³£×öרÀûÎÄÏ׵ļìË÷£¬ÓÐʱºòÐèҪͨ¹ý¶àÖÖ;¾¶²ÅÄÜÃüÖÐÄ¿±ê¡£½¨ÒéÓÃÏà¹ØÊÊӦ֢Ϊ¼ìË÷´Ê£¬È»ºóÔÙÖð²½ÒÔ¹«Ë¾Ãû³Æ¡¢°ÐµãÃû³ÆµÈËõС·¶Î§¡£

[ ·¢×ÔСľ³æ¿Í»§¶Ë ]
ÐÄÓжà´ó£¬Ìì¿Õ¾ÍÓжà´ó£¡£¡
7Â¥2013-11-11 22:12:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 7 ¸ö»Ø´ð

whatt

ľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
mollyzhang: ½ð±Ò+1, ¡ïÓаïÖú 2013-11-11 15:39:22
ÄãÒÔʲô¹Ø¼ü´Ê¼ìË÷µÄ£¿

[ ·¢×ÔСľ³æ¿Í»§¶Ë ]
ÐÄÓжà´ó£¬Ìì¿Õ¾ÍÓжà´ó£¡£¡
2Â¥2013-11-10 22:04:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

williamxiang

ľ³æ (ÖøÃûдÊÖ)


¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
mollyzhang: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú, лл£¬Çë¶à¶àÖ¸½Ì 2013-11-11 15:39:39
Ç×£¬Äã˵µÄÊÇ×÷ÓÃÓڰеãµÄ»¯ºÏÎﻹÊǰе㵰°×±¾Éí°¡£¿
Èç¹ûÊǰе㱾ÉíµÄ»°£¬
ÎÒ¾õµÃ£º
µÚÒ»£¬×÷ΪһÖÖÓÚÈËÌåÄÚÌìÈ»´æÔÚµÄÎïÖÊ£¬GPR120ÊÇ·ñÊôÓÚרÀû·¨ÒâÒåÉϵĿÍÌåÖµµÃ¿¼ÂÇ¡£¡¶×¨Àû·¨¡·£¨2008Äê°æ£©µÚ25Ìõ¹æ¶¨Á˼¸ÖÖ²»ÊÚÓèרÀûȨµÄ¼¸ÖÖ¿ÍÌ壬GPR120ÓëµÚÒ»¿î¡°¿ÆÑ§·¢ÏÖ¡±ÆÄΪÏàËÆ¡£
µÚ¶þ£¬ÔÚPUBMEDÖмì³ö±¨µÀÓÐGPR120×îÔçµÄÎÄÏ×ÊÇ2003ÄêµÄ£¬×÷Õßµ¥Î»ÊÇDepartment of Neuroscience, Uppsala University, BMC¡­¡­Òò´Ë£¬ÕâÒ»µ°°×ÖÁÉÙÔÚ2003Äê»ò¸üÔç¼´ÒѽøÈ빫֪ÁìÓò£¬ËùÒÔ¼´Ê¹Äã˵µÄÄÇЩ¹«Ë¾±Ü¿ª¿ÍÌåÉó²éÕϰ­¶øÏò¸÷רÀû¾ÖµÝ½»ÉêÇ룬Ҳ»áÒòΪ²»´æÔÚÐÂÓ±ÐÔ¶ø±»²µ»Ø¡£Ò»°ãµÄ¹«Ë¾ÊDz»»á×öÕâÖÖ´Àʵġ£
3Â¥2013-11-11 08:40:49
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mollyzhang

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

ÒýÓûØÌû:
2Â¥: Originally posted by whatt at 2013-11-10 22:04:54
ÄãÒÔʲô¹Ø¼ü´Ê¼ìË÷µÄ£¿

ÎÒÊÇÒòΪÔÚÌÀÄ·Ñ·Öв鵽ÒÔÉϵĹ«Ë¾ÔÚ×ö¸Ã°Ðµã, ËùÒÔÊÇÒÔ¹«Ë¾Ãû³Æ¼ìË÷µÄ,Æä´ÎÎÒÒÔ GPR120 (FFA4)Ò²¶¼Ã»ËÑË÷µ½ÉÏÊö¹«Ë¾µÄרÀû
4Â¥2013-11-11 15:37:04
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[ÎÄѧ·¼²ÝÔ°] »ï°éÃÇ£¬×£ÎÒÉúÈÕ¿ìÀÖ°É +17 myrtle 2026-03-10 26/1300 2026-03-16 18:32 by Çà³ÈLn
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] 0856Çóµ÷¼Á +3 ÁõÃÎ΢ 2026-03-15 3/150 2026-03-16 10:00 by houyaoxu
[¿¼ÑÐ] ²ÄÁÏר˶326Çóµ÷¼Á +4 Ä«ìÏæ¦Ý· 2026-03-15 4/200 2026-03-15 11:02 by dyw
[¿¼ÑÐ] 268Çóµ÷¼Á +5 Ò»¶¨ÓÐѧÉÏ- 2026-03-14 6/300 2026-03-14 22:20 by ÔËÆøyunqi
[¿¼ÑÐ] ±¾¿ÆÄϾ©´óѧһ־Ը´¨´óҩѧ327 +3 ÂóÌï¸ûÕß 2026-03-14 3/150 2026-03-14 20:04 by ÍâÐÇÎÄÃ÷
[¿¼ÑÐ] ²ÄÁÏ080500µ÷¼ÁÇóÊÕÁô +3 Ò»¿Åmeteor 2026-03-13 3/150 2026-03-14 10:54 by peike
[¿¼ÑÐ] 306Çóµ÷¼Á +4 ÌÆÞ²Þ² 2026-03-09 4/200 2026-03-14 01:19 by JourneyLucky
[¿¼ÑÐ] ¿¼ÑвÄÁÏÓ뻯¹¤£¬Çóµ÷¼Á +8 Ï·¾«µ¤µ¤µ¤ 2026-03-09 8/400 2026-03-14 01:14 by JourneyLucky
[¿¼ÑÐ] 265Çóµ÷¼Á +9 Сľ³æ085600 2026-03-09 12/600 2026-03-14 01:11 by JourneyLucky
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐũҵ´óѧ071010£¬×Ü·ÖÈý°Ù¶þ,Çóµ÷¼Á +3 À§À§À§À§À¤À¤ 2026-03-10 3/150 2026-03-14 00:35 by JourneyLucky
[¿¼ÑÐ] 311Çóµ÷¼Á +8 zchqwer 2026-03-10 8/400 2026-03-14 00:01 by JourneyLucky
[¿¼ÑÐ] ¹¤¿Æ£¬Çóµ÷¼Á +3 ÎÒ887 2026-03-11 3/150 2026-03-13 21:39 by JourneyLucky
[¿¼ÑÐ] 329Çóµ÷¼Á +3 miaodesi 2026-03-12 4/200 2026-03-13 20:53 by 18595523086
[¿¼ÑÐ] Çóµ÷¼Á +7 18880831720 2026-03-11 7/350 2026-03-13 16:10 by JourneyLucky
[¿¼ÑÐ] ¿¼Ñе÷¼Á +4 ·Ò´ï46 2026-03-12 4/200 2026-03-13 16:04 by ruiyingmiao
[¿¼ÑÐ] һ־Ըɽ´ó07»¯Ñ§ 332·Ö ËÄÁù¼¶Òѹý ±¾¿ÆÉ½¶«Ë«·Ç Çóµ÷¼Á£¡ +3 ²»ÏëÀíÄã 2026-03-12 3/150 2026-03-13 14:18 by JourneyLucky
[¿¼ÑÐ] 0856»¯¹¤Ô­Àí +6 z2839474511 2026-03-10 6/300 2026-03-13 10:41 by houyaoxu
[¿¼ÑÐ] 420Çóµ÷¼Á +4 ĪÏòÍâÇó11 2026-03-10 6/300 2026-03-12 14:41 by ruiyingmiao
[¿¼²©] 26É격ÇóÖú +3 ÌøÔ¾±ý¸É 2026-03-10 4/200 2026-03-10 21:15 by Tntcnn
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û